top of page

Is Robotic Surgery Killing Itself?

Foto do escritor: Carlos E Costa Almeida
Carlos E Costa Almeida
há 3 dias
5 min de leitura

Innovation, Evidence, and the Danger of Indiscriminate Adoption

 

I recently came across a report published by AGENAS (Italian National Agency for Regional Healthcare Services) evaluating the clinical outcomes of robotic surgery in general surgery, gynecology, and urology in Italy.


The findings presented in this report could have far-reaching implications for the future of robotic surgery. Why?


The development of robotic surgery was initially influenced, in part, by military applications. One of the objectives was to create systems that would allow surgeons to perform operations remotely on the battlefield, without exposing surgical teams to the dangers of armed conflict. However, this vision has not yet been fully realized, as safe and reliable remote surgery still faces significant technological challenges, particularly regarding network stability, latency, and connectivity, even with advances such as 5G technology.


As this original vision has not yet been fully achieved, robotic surgical systems have increasingly been promoted for their potential to improve clinical outcomes in conventional surgical procedures performed in hospitals worldwide. Robotic technology has often been presented to surgeons as the pinnacle of surgical innovation — something they must embrace if they want to remain at the forefront of modern surgery.


But is this perception justified by clinical outcomes? Does robotic surgery truly offer advantages to patients?


The AGENAS Report — What Did They Find?


In 2025, AGENAS published a Health Technology Assessment (HTA) report evaluating the outcomes of robotic surgery in general surgery, gynecology, and urology compared with conventional approaches, including laparoscopy and open surgery, in Italian hospitals. Its conclusions have sparked considerable debate among surgeons.

The report analyzed 22 surgical procedures and included three robotic systems: da Vinci (Intuitive Surgical), Hugo RAS (Medtronic), and Versius (CMR Surgical). Interestingly, in 2023, open surgery remained the most commonly used approach (46%), followed by conventional laparoscopy (45%) and robotic surgery (9%).


Three main areas deserve  particular attention:


1. Safety and Effectiveness

  • Robotic surgery was associated with a consistent reduction in blood loss compared with open and conventional laparoscopic surgery.

  • However, other outcomes, including oncological and functional results, were generally comparable.

  • In gynecology, robotic surgery was associated with fewer complications than open surgery, but complication rates were similar to those of conventional laparoscopy.

  • Robotic radical prostatectomy demonstrated better postoperative functional outcomes.

2. Economic Impact

  • In the absence of robust evidence demonstrating superior clinical outcomes, the higher costs associated with robotic surgery are difficult to justify, despite a modest reduction in hospital length of stay.

3. Organizational Considerations

  • Proper operating room configuration, effective team coordination, and specialized training are essential for the safe and effective implementation of robotic surgery.


What Does This Mean for the Future of Robotic Surgery?


In my opinion, the first two points are particularly important. I strongly believe that financial considerations should not be the primary factor guiding decision-making in healthcare systems. Clinical outcomes must come first. If a technology consistently delivers better clinical outcomes, healthcare systems should make every reasonable effort to invest in the resources necessary to provide those benefits to patients.


However, the AGENAS report concluded that robotic surgery is associated with higher costs without consistent evidence of superior clinical outcomes across the procedures analyzed. This is where danger becomes evident.


Robotic surgery could become the victim of its own indiscriminate adoption.

Could this report eventually "kill" robotic surgery?


Well... not that easy.


There are surgical procedures in which robotic surgery may offer meaningful clinical advantages. For instance, robotic surgery facilitates dissection in the confined pelvic space during low rectal cancer resection. Although results are not consistent across all papers, randomized clinical trials have demonstrated improved oncological and functional outcomes compared with conventional laparoscopy. Similarly, as highlighted by the AGENAS report, robotic radical prostatectomy is associated with better postoperative functional outcomes.


These examples illustrate that robotic surgery should not be judged solely on its overall results across multiple surgical procedures.


So, what is the real threat to robotic surgery?


In my opinion, this report cannot "kill" robotic surgery. However, the blind generalization of this technology by surgeons and medical technology companies might eventually do so. Surgeons must not be swayed by unrealistic promises promoted by those with financial interests in the widespread adoption of robotic surgery.


Healthcare policymakers may use the overall clinical and economic outcomes of robotic surgery to support institutional decisions aimed at reducing healthcare expenditure. Surgeons and medical technology companies must be smarter. Rather than promoting robotic surgery as the best option for virtually every surgical procedure, we should identify those procedures in which it truly delivers meaningful, sustained clinical advantages that justify its higher costs. Otherwise, if robotic surgery continues to expand into procedures where it provides essentially the same outcomes as conventional laparoscopy, this may strengthen the arguments against further public investment in robotic technology. And this is where the real danger lies.


The indiscriminate use of robotic surgery could ultimately jeopardize access to this technology for the patients who genuinely benefit from it. In the end, the benefits demonstrated in a limited number of procedures may be overshadowed by the lack of additional benefits in many others.


Perhaps the greatest threat to the future of robotic surgery is not its higher cost, but the indiscriminate adoption of a technology without sufficient evidence of clinical superiority. Innovation is essential to the progress of surgery. But innovation should be driven by better patient outcomes, not simply by the desire to use the latest technology.


Surgeons must remain critical and independent. We should not allow ourselves to be drawn into unrealistic promises or illusory expectations promoted by those with financial interests in the widespread adoption of robotic surgery.


But we must also recognize our own responsibility. The desire to be among the first, or among the few, to perform robotic surgery can sometimes be driven more by professional ambition and ego than by genuine clinical benefits for patients. This pursuit of recognition and technological prestige may encourage the indiscriminate and unjustified use of robotic surgery, ultimately contributing to the very threat we should be trying to avoid: its own decline.

Technological enthusiasm must never replace scientific evidence, commercial interests must never dictate surgical decisions, and surgeons' egos must never take precedence over patient outcomes.


Our responsibility is to our patients, not to our egos, the technology, or the companies behind it.


Finally, I would like to leave you with a thought shared by a great Italian surgeon and a personal friend: "Robotic surgery may compensate for a lack of surgical skills, while simultaneously contributing to the loss of those very skills.” A paradox worth reflecting on.


Link to AGENAS report (abstract)


Dr. Carlos Eduardo Costa Almeida

General Surgeon


1 comentário


Manuel Mega
Manuel Mega
há 3 dias

Dear Carlos, my good and enlightened friend:

I read this thought-provoking contribution with considerable interest and broadly share its concern regarding the uncritical and potentially indiscriminate adoption of robotic surgery. The argument that the value of a technology must be assessed in a procedure-specific, patient-centred and context-dependent manner is particularly pertinent.

Nevertheless, the absence of consistent superiority over conventional approaches should not automatically be interpreted as an absence of clinical value. In appropriately selected indications, robotic surgery may offer meaningful advantages, including improved ergonomics, enhanced technical feasibility in anatomically demanding scenarios, reduced conversion rates, or broader access to minimally invasive surgery. Such benefits may be clinically relevant even in the absence of superiority across all conventional outcome measures.

The central…

Curtir

KEEP CALM,

ITS SURGERY

Listen, See and Learn, before YOU DO

  • Grey Google+ Icon
  • Grey Twitter Icon
  • Grey LinkedIn Icon
  • Grey Facebook Icon

© 2023 by Talking Business.  Proudly created with Wix.com

​

bottom of page